Latest BCLI reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Brainstorm Cell Therapeutics BCLI

$ 0.35 2.37%

Brainstorm Cell Therapeutics Total Assets 2011-2024 | BCLI

Annual Total Assets Brainstorm Cell Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.21 M	8.45 M	29.3 M	51.3 M	6.53 M	11.2 M	11.4 M	10.8 M	17.1 M	9.91 M	4.73 M	5.31 M	2.74 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
51.3 M	2.74 M	13.3 M

Quarterly Total Assets Brainstorm Cell Therapeutics

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.35 M	4.21 M	5.68 M	5.75 M	7.87 M	8.45 M	13.3 M	19 M	25.8 M	29.3 M	34.5 M	42.2 M	48.6 M	51.3 M	51.3 M	51.3 M	51.3 M	6.53 M	6.53 M	6.53 M	6.53 M	11.2 M	11.2 M	11.2 M	11.2 M	11.4 M	11.4 M	11.4 M	11.4 M	10.8 M	10.8 M	10.8 M	10.8 M	17.1 M	17.1 M	17.1 M	17.1 M	9.91 M	9.91 M	9.91 M	9.91 M	4.73 M	4.73 M	4.73 M	4.73 M	5.14 M	5.31 M	5.31 M	5.31 M	2.74 M	2.74 M	2.74 M	2.74 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
51.3 M	2.74 M	14.6 M